Wednesday, July 15, 2020

Health Catalyst Inc. [HCAT] Stock trading around $32.41 per share: What’s Next?

Must read

MEDNAX Inc. Reports Revenue at $3.51 billion with dropping -34.08% YTD as MD Appoints New CEO

MEDNAX Inc. price surged by 3.80 percent to reach at $0.67. The company on July 13 announced that its Board of Directors has...

Genesis Energy L.P. [GEL] Targets a New Price of $10.92; A Good Choice for Investors?

Genesis Energy L.P. jumped around 0.43 points on Friday, while shares priced at $6.47 at the close of the session, up 7.12%. The...

Tonix Pharmaceuticals Holding Corp. [TNXP] Is Currently 8.98 above its 200 Period Moving Avg: Fundamental Overview

Tonix Pharmaceuticals Holding Corp. closed the trading session at $0.66 on 07/08/20. The day’s price range saw the stock hit a low of...

Great Western Bancorp Inc. Declares Q3 Earnings Call with GWB Revenue down -62.49% YTD

Great Western Bancorp Inc. price surged by 7.51 percent to reach at $0.91. Recently, the company announced that it will be publishing the...

Health Catalyst Inc. [NASDAQ: HCAT] loss -1.40% on the last trading session, reaching $32.41 price per share at the time. Health Catalyst Inc. represents 37.11 million in outstanding shares, while the company has a total market value of $1.23 billion with the latest information. HCAT stock price has been found in the range of $32.0019 to $33.705.

If compared to the average trading volume of 826.45K shares, HCAT reached a trading volume of 1098696 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Health Catalyst Inc. [HCAT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HCAT shares is $40.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HCAT stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Stifel have made an estimate for Health Catalyst Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 18, 2020. While these analysts kept the previous recommendation, Evercore ISI raised their target price to Outperform. The new note on the price target was released on June 15, 2020, representing the official price target for Health Catalyst Inc. stock. Previously, the target price had yet another raise to $33, while Guggenheim analysts kept a Buy rating on HCAT stock.

The Average True Range (ATR) for Health Catalyst Inc. is set at 1.54, with the Price to Sales ratio for HCAT stock in the period of the last 12 months amounting to 7.47. The Price to Book ratio for the last quarter was 5.89, with the Price to Cash per share for the same quarter was set at 5.39.

Trading performance analysis for HCAT stock

Health Catalyst Inc. [HCAT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.31. With this latest performance, HCAT shares gained by 14.28% in over the last four-week period, additionally sinking by -5.98% over the last 6 months .

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HCAT stock in for the last two-week period is set at 68.67, with the RSI for the last a single of trading hit 72.58, and the three-weeks RSI is set at 64.03 for Health Catalyst Inc. [HCAT]. The present Moving Average for the last 50 days of trading for this stock 27.67, while it was recorded at 31.64 for the last single week of trading, and 30.84 for the last 200 days.

Health Catalyst Inc. [HCAT]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Health Catalyst Inc. [HCAT] shares currently have an operating margin of -35.12 and a Gross Margin at +45.50. Health Catalyst Inc.’s Net Margin is presently recorded at -38.79.

Return on Total Capital for HCAT is now -34.52, given the latest momentum, and Return on Invested Capital for the company is -38.95. Return on Equity for this stock declined to -50.99, with Return on Assets sitting at -29.08. When it comes to the capital structure of this company, Health Catalyst Inc. [HCAT] has a Total Debt to Total Equity ratio set at 26.25. Additionally, HCAT Total Debt to Total Capital is recorded at 20.79, with Total Debt to Total Assets ending up at 17.42. Long-Term Debt to Equity for the company is recorded at 24.85, with the Long-Term Debt to Total Capital now at 19.68.

Reflecting on the efficiency of the workforce at the company, Health Catalyst Inc. [HCAT] managed to generate an average of -$66,773 per employee. Receivables Turnover for the company is 5.61 with a Total Asset Turnover recorded at a value of 0.75.Health Catalyst Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.00 and a Current Ratio set at 5.00.

Health Catalyst Inc. [HCAT]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, Health Catalyst Inc. posted -0.21/share EPS, while the average EPS was predicted by analysts to be reported at -0.3/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 30.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HCAT.

An analysis of insider ownership at Health Catalyst Inc. [HCAT]

There are presently around $898 million, or 73.60% of HCAT stock, in the hands of institutional investors. The top three institutional holders of HCAT stocks are: SC US (TTGP), LTD. with ownership of 3,089,191, which is approximately -50% of the company’s market cap and around 1.80% of the total institutional ownership; NORWEST VENTURE PARTNERS XI, LP, holding 2,352,091 shares of the stock with an approximate value of $77.31 million in HCAT stocks shares; and NORWEST VENTURE PARTNERS XII, LP, currently with $77.31 million in HCAT stock with ownership of nearly -20.325% of the company’s market capitalization.

Positions in Health Catalyst Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 92 institutional holders increased their position in Health Catalyst Inc. [NASDAQ:HCAT] by around 9,640,768 shares. Additionally, 26 investors decreased positions by around 5,743,407 shares, while 9 investors held positions by with 11,922,315 shares. The mentioned changes placed institutional holdings at 27,306,490 shares, according to the latest SEC report filing. HCAT stock had 42 new institutional investments in for a total of 3,233,766 shares, while 12 institutional investors sold positions of 221,982 shares during the same period.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

MEDNAX Inc. Reports Revenue at $3.51 billion with dropping -34.08% YTD as MD Appoints New CEO

MEDNAX Inc. price surged by 3.80 percent to reach at $0.67. The company on July 13 announced that its Board of Directors has...

Meredith Corporation Is 2.65 below its 200 Period Moving Avg as PARENTS List 100 New Books

Meredith Corporation gained 2.65% or 0.36 points to close at $13.94 with a heavy trading volume of 980497 shares. In a recent press...

American Water Works Company Awards Art Contest Winners after AWK Declines by -0.31

American Water Works Company Inc. closed the trading session at $132.97 on 07/13/20. The day’s price range saw the stock hit a low...

Henry Schein Accepts 2021 Program Applications with HSIC Targeting New Price of $63.77

Henry Schein Inc. jumped around 0.69 points on Monday, while shares priced at $57.85 at the close of the session, up 1.21%. On...

Liberty TripAdvisor Holdings to Conduct Quarterly Q&A session as LTRPA trades around $2.15

Liberty TripAdvisor Holdings Inc. stock went on a downward path that fall over -5.70% on Monday, amounting to a one-week price decrease of...